{"id":46912,"date":"2017-05-02T11:33:01","date_gmt":"2017-05-02T15:33:01","guid":{"rendered":"https:\/\/asweetlife.org\/?p=46912"},"modified":"2017-05-02T15:14:33","modified_gmt":"2017-05-02T19:14:33","slug":"jdrf-t1d-fund-invests-in-tetragenetics","status":"publish","type":"post","link":"https:\/\/asweetlife.org\/?p=46912","title":{"rendered":"JDRF T1D Fund Invests in TetraGenetics"},"content":{"rendered":"
\n
\n
\n

Today, TetraGenetics<\/a>, a biopharmaceutical company developing novel therapeutics for autoimmune diseases, announced it has received an investment\u00a0from the JDRF T1D Fund. Financial terms of the investment were not disclosed.<\/p>\n

The JDRF T1D Fund<\/a>\u00a0is a venture philanthropy fund accelerating life-changing solutions to treat, prevent, and cure type 1 diabetes (T1D) through catalytic commercial investments. Through its investments in partnership with private capital, including venture capital, pharma and foundations, the T1D Fund seeks to attract the private investment necessary to advance drugs, devices, diagnostics, and vaccines into the hands of those living with T1D. The T1D Fund will invest in areas strategically aligned with JDRF, with an exclusive focus on the best commercial opportunities. The T1D Fund will reinvest any realized gains into new investments to further its mission.<\/p>\n

The companies’ press release explains that in T1D, a subset of immune cells (antigen-specific T-cells referred to as effector memory T-cells) attack and destroy insulin-producing beta cells in the pancreas. These effector memory T-cells are associated with the autoimmune cascade that causes type 1 diabetes and they contain high levels of the Kv1.3 ion channel proteins. The Kv1.3 ion channel has been well studied, but developing drug candidates that block its activity has been difficult. TetraGenetics used its proprietary technology to discover a pool of novel monoclonal antibodies that inhibit Kv1.3 activity. The monoclonal antibodies discovered by TetraGenetics can target the Kv1.3 ion channel proteins, thus having the potential to blunt the body\u2019s attack on its own healthy beta cells. This therapy could play a role in secondary prevention and treatment of T1D, and may contribute, in combination with other therapies, to an eventual cure.<\/p>\n

“This has the potential to be a first-in-class disease modifying immunotherapy for T1D,” said Jonathan Behr, Managing Director of the T1D Fund. “We are excited to invest in the critical work necessary to advance delivery of potentially transformational therapeutics for those with T1D.\u201d<\/p>\n

Douglas Kahn, Chairman and CEO of TetraGenetics said, \u201cSupport from the JDRF T1D Fund couldn\u2019t have come at a better time, enabling us to select the best of our antibodies and advance our lead drug candidate in preparation for clinical trials. The investment funding and access to JDRF experts will significantly accelerate our T1D drug development program.\u201d<\/p>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

…<\/p>\n","protected":false},"author":131,"featured_media":46915,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"image","meta":{"_relevanssi_hide_post":"","_relevanssi_hide_content":"","_relevanssi_pin_for_all":"","_relevanssi_pin_keywords":"","_relevanssi_unpin_keywords":"","_relevanssi_related_keywords":"","_relevanssi_related_include_ids":"","_relevanssi_related_exclude_ids":"","_relevanssi_related_no_append":"","_relevanssi_related_not_related":"","_relevanssi_related_posts":"","_relevanssi_noindex_reason":"","footnotes":""},"categories":[1445],"tags":[],"yoast_head":"\nJDRF T1D Fund Invests in TetraGenetics<\/title>\n<meta name=\"description\" content=\"TetraGenetics has announced it has received an investment from the JDRF T1D Fund. Financial terms of the investment were not disclosed.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/asweetlife.org\/?p=46912\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"ASweetLife Team\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/asweetlife.org\/?p=46912\",\"url\":\"https:\/\/asweetlife.org\/?p=46912\",\"name\":\"JDRF T1D Fund Invests in TetraGenetics\",\"isPartOf\":{\"@id\":\"https:\/\/asweetlife.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/asweetlife.org\/?p=46912#primaryimage\"},\"image\":{\"@id\":\"https:\/\/asweetlife.org\/?p=46912#primaryimage\"},\"thumbnailUrl\":\"https:\/\/asweetlife.org\/wp-content\/uploads\/2017\/05\/jdrf-t1d-fund-invests-in-tetragenetics.jpg\",\"datePublished\":\"2017-05-02T15:33:01+00:00\",\"dateModified\":\"2017-05-02T19:14:33+00:00\",\"author\":{\"@id\":\"https:\/\/asweetlife.org\/#\/schema\/person\/5de2b093878b82b0ea97917f8fd72585\"},\"description\":\"TetraGenetics has announced it has received an investment from the JDRF T1D Fund. Financial terms of the investment were not disclosed.\",\"breadcrumb\":{\"@id\":\"https:\/\/asweetlife.org\/?p=46912#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/asweetlife.org\/?p=46912\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/asweetlife.org\/?p=46912#primaryimage\",\"url\":\"https:\/\/asweetlife.org\/wp-content\/uploads\/2017\/05\/jdrf-t1d-fund-invests-in-tetragenetics.jpg\",\"contentUrl\":\"https:\/\/asweetlife.org\/wp-content\/uploads\/2017\/05\/jdrf-t1d-fund-invests-in-tetragenetics.jpg\",\"width\":607,\"height\":400,\"caption\":\"JDRF T1D Fund Invests in TetraGenetics\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/asweetlife.org\/?p=46912#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/asweetlife.org\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"JDRF T1D Fund Invests in TetraGenetics\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/asweetlife.org\/#website\",\"url\":\"https:\/\/asweetlife.org\/\",\"name\":\"ASweetLife\",\"description\":\"The Diabetes Magazine\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/asweetlife.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/asweetlife.org\/#\/schema\/person\/5de2b093878b82b0ea97917f8fd72585\",\"name\":\"ASweetLife Team\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/asweetlife.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/ba76b5c6c27d32738b13f9a8a5cfcf02?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/ba76b5c6c27d32738b13f9a8a5cfcf02?s=96&d=mm&r=g\",\"caption\":\"ASweetLife Team\"},\"url\":\"https:\/\/asweetlife.org\/?author=131\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"JDRF T1D Fund Invests in TetraGenetics","description":"TetraGenetics has announced it has received an investment from the JDRF T1D Fund. Financial terms of the investment were not disclosed.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/asweetlife.org\/?p=46912","twitter_misc":{"Written by":"ASweetLife Team","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/asweetlife.org\/?p=46912","url":"https:\/\/asweetlife.org\/?p=46912","name":"JDRF T1D Fund Invests in TetraGenetics","isPartOf":{"@id":"https:\/\/asweetlife.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/asweetlife.org\/?p=46912#primaryimage"},"image":{"@id":"https:\/\/asweetlife.org\/?p=46912#primaryimage"},"thumbnailUrl":"https:\/\/asweetlife.org\/wp-content\/uploads\/2017\/05\/jdrf-t1d-fund-invests-in-tetragenetics.jpg","datePublished":"2017-05-02T15:33:01+00:00","dateModified":"2017-05-02T19:14:33+00:00","author":{"@id":"https:\/\/asweetlife.org\/#\/schema\/person\/5de2b093878b82b0ea97917f8fd72585"},"description":"TetraGenetics has announced it has received an investment from the JDRF T1D Fund. Financial terms of the investment were not disclosed.","breadcrumb":{"@id":"https:\/\/asweetlife.org\/?p=46912#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/asweetlife.org\/?p=46912"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/asweetlife.org\/?p=46912#primaryimage","url":"https:\/\/asweetlife.org\/wp-content\/uploads\/2017\/05\/jdrf-t1d-fund-invests-in-tetragenetics.jpg","contentUrl":"https:\/\/asweetlife.org\/wp-content\/uploads\/2017\/05\/jdrf-t1d-fund-invests-in-tetragenetics.jpg","width":607,"height":400,"caption":"JDRF T1D Fund Invests in TetraGenetics"},{"@type":"BreadcrumbList","@id":"https:\/\/asweetlife.org\/?p=46912#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/asweetlife.org\/"},{"@type":"ListItem","position":2,"name":"JDRF T1D Fund Invests in TetraGenetics"}]},{"@type":"WebSite","@id":"https:\/\/asweetlife.org\/#website","url":"https:\/\/asweetlife.org\/","name":"ASweetLife","description":"The Diabetes Magazine","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/asweetlife.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/asweetlife.org\/#\/schema\/person\/5de2b093878b82b0ea97917f8fd72585","name":"ASweetLife Team","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/asweetlife.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/ba76b5c6c27d32738b13f9a8a5cfcf02?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ba76b5c6c27d32738b13f9a8a5cfcf02?s=96&d=mm&r=g","caption":"ASweetLife Team"},"url":"https:\/\/asweetlife.org\/?author=131"}]}},"_links":{"self":[{"href":"https:\/\/asweetlife.org\/index.php?rest_route=\/wp\/v2\/posts\/46912"}],"collection":[{"href":"https:\/\/asweetlife.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/asweetlife.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/asweetlife.org\/index.php?rest_route=\/wp\/v2\/users\/131"}],"replies":[{"embeddable":true,"href":"https:\/\/asweetlife.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=46912"}],"version-history":[{"count":5,"href":"https:\/\/asweetlife.org\/index.php?rest_route=\/wp\/v2\/posts\/46912\/revisions"}],"predecessor-version":[{"id":46926,"href":"https:\/\/asweetlife.org\/index.php?rest_route=\/wp\/v2\/posts\/46912\/revisions\/46926"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/asweetlife.org\/index.php?rest_route=\/wp\/v2\/media\/46915"}],"wp:attachment":[{"href":"https:\/\/asweetlife.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=46912"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/asweetlife.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=46912"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/asweetlife.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=46912"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}